SGYP
Synergy Pharmaceuticals, Inc Common Stock
SGYP
SGYP
Delisted
SGYP was delisted on the 7th of March, 2019.
134 hedge funds and large institutions have $386M invested in Synergy Pharmaceuticals, Inc Common Stock in 2016 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 51 increasing their positions, 31 reducing their positions, and 21 closing their positions.
Holders
134
Holders Change
+6
Holders Change %
+4.69%
% of All Funds
3.58%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
27
Increased
51
Reduced
31
Closed
21
Calls
$4.64M
Puts
$2.74M
Net Calls
+$1.91M
Net Calls Change
-$1.58M
Top Buyers
| 1 |
PC
1
Paulson & Co
New York
|
$105M |
| 2 |
2
Vanguard Group
Malvern,
Pennsylvania
|
$46.8M |
| 3 |
GPP
3
Great Point Partners
Greenwich,
Connecticut
|
$28.8M |
| 4 |
O
4
OrbiMed
New York
|
$22.7M |
| 5 |
BFA
5
BlackRock Fund Advisors
San Francisco,
California
|
$33.5M |
Top Sellers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
151
Barclays
London,
United Kingdom
| – | – | -14,213 | Closed |
|
|
PCM
152
Prelude Capital Management
New York
| – | – | -10,000 | Closed |
|
153
Walleye Trading
New York
| – | – | -1,300 | Closed |
|
|
TAM
154
TFG Asset Management
Grand Cayman,
Cayman Islands
| – | – | – | – |
|
|
EWM
155
Edge Wealth Management
New York
| $0 | 50 | – | – |
|
|
RCG
156
Ruggie Capital Group
Tavares,
Florida
| $0 | 55 | +55 | New |
|